BO1.F
BioCryst Pharmaceuticals, Inc.
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
8.19
▲ 0.02 (0.29%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
8.19
Prev close
8.17
Day high
8.19
Day low
8.19
Volume
2.00K
Market cap
$2.09B
P/E (TTM)
—
52W range
5.18 – 10.19
Day trading desk
Gap from prior close
+0.29%
Prior close 8.17
VWAP
—
—
Relative volume
0.00×
Quiet session
Session range
—
8.19 – 8.19
Position in range
—
—
ATR (14D)
0.28
3.45% of price
Prior day high
8.17
PDH
Prior day low
8.17
PDL
Bid / ask spread
—
Quote not published
Session volume
—
Avg 70
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-1.42%
-0.2%
1M
+0.54%
-2.8%
3M
+13.96%
+11.6%
6M
+29.20%
+17.3%
YTD
+27.12%
+15.1%
1Y
+13.52%
-6.6%
3Y
+29.12%
-45.9%
5Y
-35.43%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BO1.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
3.05M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 11, 26 | LEVIN ALAN G Director |
STOCK | 15.29K | $0 | Direct |
| Jun 11, 26 | GALSON STEVEN K Director |
STOCK | 15.29K | $0 | Direct |
| Jun 11, 26 | FRANK STEVEN R Director |
STOCK | 15.29K | $0 | Direct |
| Jun 11, 26 | MILNE JILL C. PH.D. Director |
STOCK | 15.29K | $0 | Direct |
| Jun 11, 26 | SANDERS MACHELLE Director |
STOCK | 15.29K | $0 | Direct |
| Jun 11, 26 | HEGGIE THERESA Director |
STOCK | 15.29K | $0 | Direct |
| Jun 11, 26 | MCKEE AMY E Director |
STOCK | 15.29K | $0 | Direct |
| Jun 11, 26 | MILANO VINCENT J Director |
STOCK | 15.29K | $0 | Direct |
| Jun 11, 26 | STONEHOUSE JON P Director |
STOCK | 15.29K | $0 | Direct |
| May 29, 26 | FRANK STEVEN R Director |
STOCK | 1.26K | $11.24K | Direct |
| May 29, 26 | MILNE JILL C. PH.D. Director |
STOCK | 1.26K | $11.24K | Direct |
| May 29, 26 | MCKEE AMY E Director |
STOCK | 631 | $5.62K | Direct |
| May 29, 26 | MILANO VINCENT J Director |
STOCK | 1.12K | $10.00K | Direct |
| May 29, 26 | STONEHOUSE JON P Director |
STOCK | 631 | $5.62K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARNES ALANE P |
Officer | 400.70K | Conversion of Exercise of derivative security |
DOYLE ANTHONY |
Chief Financial Officer | 377.87K | Stock Award(Grant) |
GALSON STEVEN K |
Director | 86.17K | Stock Award(Grant) |
GAYER CHARLES K |
President | 952.58K | Conversion of Exercise of derivative security |
GHIAS BABAR |
Chief Financial Officer | 268.70K | Stock Award(Grant) |
HUTSON NANCY J |
Director | 99.14K | Stock Award(Grant) |
MENON SANDEEP |
Officer | 205.15K | Stock Award(Grant) |
MILANO VINCENT J |
Director | 108.48K | Stock Award(Grant) |
STONEHOUSE JON P |
Director | 1.42M | Stock Award(Grant) |
THACKRAY HELEN M |
Officer | 384.84K | Stock Award(Grant) |
Fundamentals
Market cap$2.09B
Enterprise value$2.57B
Revenue (TTM)$940.61M
Gross profit$727.92M
EBITDA$433.65M
Net income$-384.67M
EPS (TTM)$-1.20
Free cash flow$324.27M
Total cash$352.57M
Total debt$836.64M
Book value / share$-1.52
Shares outstanding255.54M
Float222.36M
Short % of float—
Dividend yield—
Beta (5Y)0.55
Valuation & profitability ratios
Trailing P/E—
Forward P/E-11.07
PEG ratio—
Price / sales—
Price / book—
EV / revenue2.73
EV / EBITDA5.93
Gross margin77.39%
Operating margin45.12%
Profit margin-40.90%
Return on equity—
Return on assets52.86%
Debt / equity—
Current ratio2.32
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $874.84M | $450.71M | $331.41M | $270.83M | +94.1% |
| Operating revenue | $874.84M | $450.71M | $331.41M | $270.83M | +94.1% |
| Cost of revenue | $19.07M | $12.27M | $4.48M | $6.59M | +55.5% |
| Gross profit | $855.76M | $438.44M | $326.93M | $264.23M | +95.2% |
| Research & development | $166.13M | $174.64M | $216.57M | $253.30M | -4.9% |
| Selling, general & admin | $348.65M | $266.35M | $214.07M | $159.37M | +30.9% |
| Total operating expense | $514.77M | $440.99M | $430.64M | $412.67M | +16.7% |
| Operating income | $340.99M | -$2.54M | -$103.71M | -$148.44M | +13,508.9% |
| Net interest income | -$68.20M | -$83.77M | -$92.46M | -$93.97M | +18.6% |
| Pre-tax income | $267.39M | -$86.95M | -$226.23M | -$244.38M | +407.5% |
| Tax provision | $3.53M | $1.93M | $310.00K | $2.73M | +83.2% |
| Net income | $263.86M | -$88.88M | -$226.54M | -$247.12M | +396.9% |
| Net income to common | $263.86M | -$88.88M | -$226.54M | -$247.12M | +396.9% |
| Basic EPS | 1.26 | -0.43 | -1.18 | -1.33 | +393.0% |
| Diluted EPS | 1.21 | -0.43 | -1.18 | -1.33 | +381.4% |
| EBIT | $346.26M | $11.56M | -$117.99M | -$145.29M | +2,894.8% |
| EBITDA | $347.65M | $12.81M | -$116.33M | -$143.85M | +2,614.3% |
| Basic shares | 209.89M | 206.70M | 192.20M | 185.91M | +1.5% |
| Diluted shares | 218.58M | 206.70M | 192.20M | 185.91M | +5.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $89.74M | $104.71M | $110.64M | $304.77M | -14.3% |
| Cash & short-term investments | $274.75M | $320.85M | $388.99M | $424.31M | -14.4% |
| Accounts receivable | $106.82M | $79.07M | $56.95M | $50.60M | +35.1% |
| Inventory | $5.40M | $8.09M | $28.68M | $27.53M | -33.3% |
| Total current assets | $404.35M | $421.97M | $495.97M | $516.50M | -4.2% |
| Property, plant & equipment | $18.99M | $19.79M | $20.91M | $8.62M | -4.0% |
| Total assets | $514.16M | $490.42M | $516.96M | $550.00M | +4.8% |
| Total current liabilities | $196.07M | $160.38M | $149.99M | $105.51M | +22.2% |
| Long-term debt | $427.23M | $795.92M | $811.26M | $733.28M | -46.3% |
| Total debt | $438.87M | $808.74M | $825.15M | $741.45M | -45.7% |
| Total liabilities | $633.31M | $966.35M | $972.49M | $844.60M | -34.5% |
| Retained earnings | -$1.51B | -$1.77B | -$1.68B | -$1.45B | +14.9% |
| Shareholder equity | -$119.15M | -$475.93M | -$455.53M | -$294.60M | +75.0% |
| Working capital | $208.28M | $261.58M | $345.98M | $410.99M | -20.4% |
| Net tangible assets | -$119.15M | -$475.93M | -$455.53M | -$294.60M | +75.0% |
| Shares issued | 213.06M | 208.54M | 205.77M | 187.91M | +2.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $263.86M | -$88.88M | -$226.54M | -$247.12M | +396.9% |
| Depreciation & amortisation | $1.39M | $1.25M | $1.66M | $1.44M | +11.5% |
| Stock-based compensation | $85.07M | $65.41M | $55.62M | $44.70M | +30.0% |
| Change in working capital | -$56.90M | -$87.28M | -$32.40M | -$58.95M | +34.8% |
| Operating cash flow | $347.37M | -$52.02M | -$95.14M | -$161.85M | +767.8% |
| Capital expenditure | -$2.47M | -$1.12M | -$2.17M | -$1.35M | -119.6% |
| Investing cash flow | -$13.69M | $52.59M | -$131.50M | -$128.24M | -126.0% |
| Financing cash flow | -$349.93M | -$5.76M | $32.48M | $88.03M | -5,974.1% |
| Free cash flow | $344.90M | -$53.14M | -$97.31M | -$163.20M | +749.0% |
| End cash position | $91.34M | $106.32M | $112.45M | $306.24M | -14.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $218.25M | $156.41M | $406.56M | $159.40M | $163.35M | — | +39.5% |
| Operating revenue | $157.51M | $151.36M | $406.56M | $159.40M | $162.43M | — | +4.1% |
| Cost of revenue | $3.84M | $5.38M | $9.52M | $2.19M | $2.80M | — | -28.6% |
| Gross profit | $214.41M | $151.04M | $397.03M | $157.21M | $160.56M | — | +42.0% |
| Research & development | $51.97M | $758.08M | $40.87M | $44.60M | $43.39M | — | -93.1% |
| Selling, general & admin | $63.98M | $94.55M | $95.78M | $83.01M | $87.38M | — | -32.3% |
| Total operating expense | $115.94M | $852.63M | $136.65M | $127.62M | $130.77M | — | -86.4% |
| Operating income | $98.47M | -$701.60M | $260.38M | $29.59M | $29.79M | — | +114.0% |
| Net interest income | -$19.28M | -$17.52M | -$11.24M | -$17.42M | -$19.07M | — | -10.0% |
| Pre-tax income | $79.47M | -$720.81M | $248.02M | $12.13M | $6.49M | — | +111.0% |
| Tax provision | $1.08M | $1.00M | $2.17M | -$769.00K | $1.40M | — | +7.5% |
| Net income | $78.39M | -$721.81M | $245.84M | $12.90M | $5.08M | — | +110.9% |
| Net income to common | $78.39M | -$721.81M | $245.84M | $12.90M | $5.08M | — | +110.9% |
| Basic EPS | 0.31 | -2.98 | 1.17 | — | 0.02 | 0.00 | +110.4% |
| Diluted EPS | 0.30 | -2.98 | 1.12 | — | 0.02 | 0.00 | +110.1% |
| EBIT | $101.19M | -$701.03M | $262.15M | $31.79M | $28.07M | — | +114.4% |
| EBITDA | $101.70M | -$700.57M | $262.55M | $32.13M | $28.40M | — | +114.5% |
| Basic shares | 254.48M | 242.26M | 210.97M | — | 209.52M | 208.88M | +5.0% |
| Diluted shares | 265.17M | 242.26M | 219.26M | — | 219.89M | 215.26M | +9.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $154.97M | $171.59M | $89.74M | $84.08M | $88.03M | -9.7% |
| Cash & short-term investments | $352.57M | $238.40M | $274.75M | $212.87M | $260.04M | +47.9% |
| Accounts receivable | $110.76M | $109.27M | $106.82M | $91.33M | $91.18M | +1.4% |
| Inventory | $6.06M | $5.99M | $5.40M | $5.23M | $5.04M | +1.2% |
| Total current assets | $484.68M | $373.63M | $404.35M | $355.68M | $398.46M | +29.7% |
| Property, plant & equipment | $21.67M | $22.98M | $18.99M | $19.24M | $20.00M | -5.7% |
| Total assets | $557.85M | $465.05M | $514.16M | $446.42M | $457.19M | +20.0% |
| Total current liabilities | $208.85M | $195.39M | $196.07M | $190.24M | $177.16M | +6.9% |
| Long-term debt | $778.38M | $802.38M | $427.23M | $633.47M | $690.64M | -3.0% |
| Total debt | $792.84M | $817.77M | $438.87M | $645.42M | $703.18M | -3.0% |
| Total liabilities | $1.01B | $1.02B | $633.31M | $834.31M | $878.78M | -0.7% |
| Retained earnings | -$2.15B | -$2.23B | -$1.51B | -$1.75B | -$1.76B | +3.5% |
| Shareholder equity | -$454.29M | -$553.84M | -$119.15M | -$387.89M | -$421.59M | +18.0% |
| Working capital | $275.84M | $178.23M | $208.28M | $165.45M | $221.30M | +54.8% |
| Net tangible assets | -$454.29M | -$553.84M | -$119.15M | -$387.89M | -$421.59M | +18.0% |
| Shares issued | 255.26M | 254.01M | 213.06M | 210.52M | 209.91M | +0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $78.39M | -$721.81M | $245.84M | $12.90M | $5.08M | — | +110.9% |
| Depreciation & amortisation | $513.00K | $461.00K | $394.00K | $335.00K | $329.00K | — | +11.3% |
| Stock-based compensation | $14.69M | $16.03M | $23.79M | $18.60M | $21.30M | — | -8.3% |
| Change in working capital | -$3.11M | -$71.40M | $4.23M | -$1.37M | $2.38M | — | +95.6% |
| Operating cash flow | $104.34M | -$61.79M | $291.96M | $41.62M | $41.30M | — | +268.9% |
| Capital expenditure | -$209.00K | -$403.00K | -$802.00K | -$1.34M | -$179.00K | — | +48.1% |
| Investing cash flow | -$110.15M | -$268.65M | -$83.49M | $13.57M | $29.13M | — | +59.0% |
| Financing cash flow | -$11.15M | $412.55M | -$217.96M | -$58.81M | -$73.69M | — | -102.7% |
| Free cash flow | $104.13M | -$62.19M | $291.16M | $40.28M | $41.12M | — | +267.4% |
| End cash position | $156.38M | $173.38M | — | — | $89.92M | $106.88M | -9.8% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $165.53M | +3.9% |
| Next quarter | — | — | $169.41M | -58.3% |
| Current year | — | — | $702.23M | -19.7% |
| Next year | — | — | $737.28M | +5.0% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders1.20%
Held by institutions105.35%
Institutions holding412
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
8.47
-3.30% from price
SMA 20
8.25
-0.70% from price
SMA 50
8.33
-1.69% from price
SMA 100
7.97
+2.81% from price
SMA 200
7.19
+13.89% from price
EMA 12
8.32
-1.56% from price
EMA 26
8.29
-1.22% from price
EMA 50
8.20
-0.08% from price
RSI (14)
48.4
Neutral
MACD (12,26,9)
0.03
Hist -0.01
ATR (14)
0.28
3.45% of price
Realised vol 30D
56.8%
Annualised
Bollinger upper
8.94
20, 2σ
Bollinger lower
7.56
20, 2σ
50 / 200 cross
Golden
8.33 vs 7.19
Trend bias
Above 200
+13.89%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.07
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
56.8%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-29.0%
Peak to trough
Max drawdown 5Y
-77.0%
Peak to trough
ATR 14
0.28
3.45% of price
Beta (reported)
0.55
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 6, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Aug 6, 26 | Wedbush | MAINTAINED | Outperform | Outperform |
| Jul 7, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jun 30, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 30, 26 | Cantor Fitzgerald | MAINTAINED | Overweight | Overweight |
| May 7, 26 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| May 7, 26 | Wedbush | MAINTAINED | Outperform | Outperform |
| May 6, 26 | Needham | MAINTAINED | Buy | Buy |
| Jan 30, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Dec 15, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 5, 25 | Citizens | MAINTAINED | Market Outperform | Market Outperform |
| Nov 4, 25 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
Headlines
Micron's Big AI Test Is Coming This Week
GuruFocus.com · 1m ago
Alibaba Slides as $10.2 Billion AI Sale Dilutes Investors
GuruFocus.com · 2m ago
Jersey Mike's Subs Same-Store Sales Growth More Durable Than Peers, RBC Says
MT Newswires · 3m ago
HearingLife Introduces Oticon Reveal, the World's First Dual AI-Powered Hearing Aid
PR Newswire · 3m ago
France readies high school phone ban for next month
AFP · 4m ago
DeepCura Unveils the Electronic Health Workforce (EHW) -- the Step Beyond the EHR
PR Newswire · 6m ago
Shipping ETF (SEA) Hits New 52-Week High
Zacks · 7m ago
Is PepsiCo's Growth Story Becoming More Internationally Focused?
Zacks · 7m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.